Syra Health (NASDAQ:SYRA – Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.11, reports. Syra Health had a negative net margin of 54.90% and a negative return on equity of 131.94%. The firm had revenue of $2.56 million for the quarter, compared to analysts’ expectations of $2.20 million.
Syra Health Trading Up 0.9%
Shares of Syra Health stock traded up $0.01 during trading on Wednesday, hitting $0.94. 23,739 shares of the stock traded hands, compared to its average volume of 41,524. The stock’s fifty day simple moving average is $0.87 and its 200 day simple moving average is $0.53. The firm has a market cap of $12.99 million, a P/E ratio of -1.44 and a beta of 2.91. Syra Health has a 52-week low of $0.06 and a 52-week high of $1.15.
Syra Health Company Profile
Syra Health Corp. is a healthcare technology and services company focused on improving access, delivery and outcomes across the U.S. healthcare system. The company develops solutions for behavioral and mental health, population health management, healthcare education and workforce needs.
Its offerings are designed to support healthcare providers, government agencies, employers and other organizations. Syra Health combines technology, data and professional services to assist with areas such as care coordination, health education, clinical workforce development, behavioral health programs and population health initiatives.
Based in Carmel, Indiana, Syra Health was established in the early 2020s and serves clients in the United States.
Read More
- Five stocks we like better than Syra Health
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.
